Scientists working to extend human lifespan to 250 years — Expert

A leading medical expert, Dr. Ibrahim Wada, has suggested that advancements in medical technology and genetic engineering could push the human lifespan to 250 years in the next 30 to 40 years.

Wada, the founder of Nisa Medical Group, made this claim while delivering the Second Nimi Dimkpa Briggs Legacy Lecture at the University of Port Harcourt (UNIPORT) on Thursday.

His lecture, titled “The Longevity of Man,” explored the rapid pace of scientific breakthroughs that may soon redefine human aging.

He pointed to remarkable progress in genetic science, highlighting the creation of artificial eggs and sperm from human saliva, which could eventually lead to babies being grown in artificial wombs.

“This technology has already produced live rats. It is only a matter of time before humans benefit from similar advancements,” he said.

Wada, an Associate Professor of Obstetrics and Gynaecology at Abubakar Tafawa Balewa University, Bauchi, noted that innovations in stem cell research, artificial organs, and genetic reprogramming could revolutionize human health and longevity.

READ ALSO:

• Lawyers fault Senate’s suspension of Natasha Akpoti-Uduaghan
• Simon Ekpa accounts frozen for alleged terrorism financing
• Bandits kill 12 Zamfara community guards, vigilantes

“Recreating stem cells from a person’s genes and reintroducing them into the body can regenerate dead cells and significantly extend lifespan,” he explained. “In another 30 to 40 years, it will be normal for individuals to expect to live for 200 or even 250 years. This will happen because humanity has now entered the age of computer reprogramming.”

Despite the potential of these innovations, Wada expressed concern that such advanced treatments are not yet accessible in Nigeria. He also underscored the importance of lifestyle choices in promoting longevity, emphasizing regular medical check-ups, a balanced diet, exercise, and adequate rest.

“Rest is essential for brain function. So, when it is time to rest, you must allow the brain to rest – no compromise,” he advised.

During the event, UNIPORT Vice-Chancellor, Prof. Owunari Georgewill, reflected on the legacy of Prof. Nimi Briggs, describing him as a visionary leader and academic powerhouse.

“This is because it is not the breath we take, but the fire we ignite,” Georgewill remarked, raising the question of whether longevity is purely biological or tied to a person’s impact on the world.

Prof. Ngozi Orazulike, Chair of the Nimi Briggs Professorial Chair in Obstetrics and Gynaecology, praised Briggs’ significant contributions to medicine, education, and philanthropy.

Meanwhile, the late professor’s son, Nima Briggs, expressed gratitude for the continued recognition of his father’s legacy.

“It is humbling to see my father’s legacy live on, with events still being organised to honour his memory,” he said.

Scientists working to extend human lifespan to 250 years — Expert

How to practise healthy Ramadan fast — Experts

Ramadan fast is a spiritual obligation for Muslims to abstain from all food and drinks from dawn to sunset for 29/30 days.

Medical experts say fasting has health benefits. They advise people observing the Ramadan fast to adopt some health practices during the period.

A consultant family physician at the Federal Teaching Hospital Gombe, Dr Nuhu Ardo Kumo, said all those observing Ramadan fast should endeavour not to miss their ‘Sahur ‘ which is eaten during pre-dawn period.

NAFDAC withdraws approval of major anti-malaria drug

The National Agency for Food and Drug Administration and Control (NAFDAC) has officially stopped the registration of Artemether/Lumefantrine dry powder for oral suspension, a widely used multi-dose anti-malarial medication.

The agency announced this decision through Public Alert No. 01/2025, posted on its website Thursday, citing concerns about the product’s stability after reconstitution, which may compromise its effectiveness.

According to the alert, “stability studies have shown that once reconstituted, the Artemether/Lumefantrine oral suspension becomes unstable, which can result in a loss of efficacy.”

This suspension covers both locally manufactured and imported versions of the product. NAFDAC stated it would no longer process new registrations, renewals, or variation applications for the drug.

READ ALSO:

• International fraud syndicates setting up cells in Nigeria – EFCC
• Senator Akpoti-Uduaghan threatens to expose Akpabio
• Ganduje says Amaechi, el-Rufai, others will regret dumping APC

The agency warned that the instability of the suspension could lead to severe health consequences, including “worsening health conditions, increased risks of complications, treatment delays, or even death.”

In response, NAFDAC has instructed its zonal directors and state coordinators to conduct surveillance operations and remove the affected products from circulation.

The agency urged healthcare professionals, distributors, and retailers to halt the importation, sale, and distribution of the product immediately. Consumers and medical practitioners have also been encouraged to report any sightings of the drug or instances of substandard or counterfeit medicines to the nearest NAFDAC office.

Reports of adverse reactions or side effects can also be submitted via NAFDAC’s E-reporting platforms or through the Med-safety app, available on both Android and iOS devices.
NAFDAC confirmed that this alert would be shared with the World Health Organisation’s Global Surveillance and Monitoring System (GSMS).

NAFDAC withdraws approval of major anti-malaria drug